A novel penetratin-modified complex for noninvasive intraocular delivery of antisense oligonucleotides-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel penetratin-modified complex for noninvasive intraocular delivery of antisense oligonucleotides

Published:2017-08 Issue:1-2 Volume:529 Page:347-356
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Tai Lingyu,Liu Chang,Jiang Kuan,Chen Xishan,Feng Linglin,Pan Weisan,Wei Gang,Lu Weiyue

Funder

National Natural Science Fund of China

Major Key Basic Research Fundamental Program of Shanghai Science and Technology Committee

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference41 articles.

1. A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases;Apaolaza;Int. J. Pharm.,2014

2. Gene therapy progress and prospects: the eye;Bainbridge;Gene Ther.,2006

3. Delivery of antisense oligonucleotide to the cornea by iontophoresis;Berdugo;Antisense Nucleic Acid Drug Dev.,2003

4. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers;Bielinska;Nucleic Acids Res.,1996

5. Ocular gene therapy;Campbell;Dev. Ophthalmol.,2016

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and strategies for ocular posterior diseases therapy via non-invasive advanced drug delivery;Journal of Controlled Release;2023-09

2. Nanotechnology-based ocular drug delivery systems: recent advances and future prospects;Journal of Nanobiotechnology;2023-07-22

3. Retinal Tissue Engineering: Regenerative and Drug Delivery Approaches;Current Stem Cell Research & Therapy;2023-07

4. Ocular therapies with biomacromolecules: From local injection to eyedrop and emerging noninvasive delivery strategies;Advanced Drug Delivery Reviews;2023-06

5. Machine learning-driven multifunctional peptide engineering for sustained ocular drug delivery;Nature Communications;2023-05-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3